Prostate cancer treatment in Europe at the end of 1990s

Gemma Gatta, Giulia Zigon, Antoine Buemi, Jan Willem Coebergh, Marc Colonna, Paolo Contiero, Louis Denis, Pascale Grosclaude, Ann Valrie Guizard, Maria Jose Sanchez-Perez, Ivan Plesko, Martina Ondrusova, Jadwiga Rachtan, Riccardo Valdagni, Michael Velten, Marina Vercelli, Franco Berrino

Research output: Contribution to journalArticle

Abstract

Background. There is wide variation in prostate cancer incidence and survival across Europe. In many countries incidence is rising sharply in relation to the introduction of prostate-specific antigen assay, and there is concern that patients may not be treated appropriately. We therefore aimed to characterize treatment for prostate cancer across Europe. Methods. We performed a high resolution population-based study, collecting information on the treatment of 3 486 prostate cancer cases diagnosed in 19951999 in 11 cancer registries from six European countries. Results. Overall, about one in three patients received radical treatment (prostatectomy 23% or radiotherapy 14%); about 60% of younger patients (70% in Calvados, Haut-Rhin, Tarn and Eindhoven and

Original languageEnglish
Pages (from-to)867-873
Number of pages7
JournalActa Oncologica
Volume48
Issue number6
DOIs
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology

Fingerprint Dive into the research topics of 'Prostate cancer treatment in Europe at the end of 1990s'. Together they form a unique fingerprint.

  • Cite this

    Gatta, G., Zigon, G., Buemi, A., Coebergh, J. W., Colonna, M., Contiero, P., Denis, L., Grosclaude, P., Guizard, A. V., Sanchez-Perez, M. J., Plesko, I., Ondrusova, M., Rachtan, J., Valdagni, R., Velten, M., Vercelli, M., & Berrino, F. (2009). Prostate cancer treatment in Europe at the end of 1990s. Acta Oncologica, 48(6), 867-873. https://doi.org/10.1080/02841860902719174